(Q43854454)

English

Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials

scientific article published on 10 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

childhood acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

A Sander

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Zimmermann

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Dworzak

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

G Fleischhack

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

C von Neuhoff

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D Reinhardt

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

G J L Kaspers

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

U Creutzig

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

10 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1422-1428

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

https://scigraph.springernature.com/pub.10.1038/leu.2010.127

0 references

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

Definition of a standard-risk group in children with AML

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

21 January 2018

Pediatric acute myeloid leukemia: international progress and future directions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved outcome after relapse in children with acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.127

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.127

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43854454&oldid=2103910449"